In a mouse CRC model, combining exogenous leptin with anti-PD-1 further boosted tumor control and increased M1 macrophage polarization in the tumor, suggesting that leptin can fuel a more potent immune attack on the tumor in the presence of immune checkpoint blockade (52). Here, LEP is linked to colorectal carcinoma.